Evidence map›Paper›PMID 34496879›Full record

ArticleThrombosis journal2021

A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1.

Yan-Ping Zhang, Bin Lin, Yuan-Yuan Ji, Ya-Nan Hu, Xin-Fu Lin, Yi Tang, Jian-Hui Zhang, Shao-Jie Wu, Sen-Lin Cai, Yan-Feng Zhou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Thrombosis journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yan-Ping Zhang *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Bin Lin *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yuan-Yuan Ji *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Ya-Nan Hu *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Xin-Fu Lin *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yi TangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Jian-Hui ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Shao-Jie WuShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Sen-Lin CaiShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yan-Feng ZhouShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Ting ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. cttc1990@126.com.
Zhu-Ting FangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. 470389481@qq.com.
Jie-Wei LuoShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. docluo0421@aliyun.com.ORCID http://orcid.org/0000-0003-4271-4848
Fujian Medical University · CNFujian University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProtein S deficiency (PSD) is an autosomal dominant hereditary disease. In 1984, familial PSD was reported to be prone to recurrent thrombosis. Follow-up studies have shown that heterozygous protein S (PROS1) mutations increase the risk of thrombosis. More than 300 PROS1 mutations have been identified; among them, only a small number of mutations have been reported its possible mechanism to reduce plasma protein S (PS) levels. However, whether PROS1 mutations affect protein structure and why it can induce PSD remains unknown.

methodsThe clinical phenotypes of the members of a family with thrombosis were collected. Their PS activity was measured using the coagulation method, whereas their protein C and antithrombin III activities were measured using methods such as the chromogenic substrate method. The proband and her parents were screened for the responsible mutation using second-generation whole exon sequencing, and the members of the family were verified for suspected mutations using Sanger sequencing. Mutant and wild type plasmids were constructed and transfected into HEK293T cells to detect the mRNA and protein expression of PROS1.

resultsIn this family, the proband with venous thrombosis of both lower extremities, the proband's mother with pulmonary embolism and venous thrombosis of both lower extremities, and the proband's younger brother had significantly lower PS activity and carried a PROS1 c. 1820 T > C:p.Leu607Ser heterozygous mutation (NM_000313.3). However, no such mutations were found in family members with normal PS activity. The PS expression in the cell lysate and supernatant of the Leu607Ser mutant cells decreased, while mRNA expression increased. Immunofluorescence localization showed that there was no significant difference in protein localization before and after mutation.

conclusionsThe analysis of family phenotype, gene association, and cell function tests suggest that the PROS1 Leu607Ser heterozygous mutation may be a pathogenic mutation. Serine substitution causes structural instability of the entire protein. These data indicate that impaired PS translation and synthesis or possible secretion impairment is the main pathogenesis of this family with hereditary PSD and thrombophilia.

Indexed as

DeficiencyMutationPROS1Protein SVein thrombosis

Identifiers

PMID34496879
PMCPMC8424916
OpenAlexW3179032211

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.